Page last updated: 2024-10-25

clobenpropit and Testicular Neoplasms

clobenpropit has been researched along with Testicular Neoplasms in 1 studies

clobenpropit: histamine H3 receptor antagonist
clobenpropit : An imidothiocarbamic ester that consists of isothiourea bearing S-3-(imidazol-4-yl)propyl and N-4-chlorobenzyl substituents. An extremely potent histamine H3 antagonist/inverse agonist (pA2 = 9.93). Also displays partial agonist activity at H4 receptors; induces eosinophil shape change with an EC50 of 3 nM.

Testicular Neoplasms: Tumors or cancer of the TESTIS. Germ cell tumors (GERMINOMA) of the testis constitute 95% of all testicular neoplasms.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abiuso, AMB1
Varela, ML1
Haro Durand, L1
Besio Moreno, M1
Marcos, A1
Ponzio, R1
Rivarola, MA1
Belgorosky, A1
Pignataro, OP1
Berensztein, E1
Mondillo, C1

Other Studies

1 other study available for clobenpropit and Testicular Neoplasms

ArticleYear
Histamine H4 receptor as a novel therapeutic target for the treatment of Leydig-cell tumours in prepubertal boys.
    European journal of cancer (Oxford, England : 1990), 2018, Volume: 91

    Topics: Age Factors; Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Aromatase; Cell Line, Tumor; C

2018